BaySaver Technologies Introduces New Storm Water Filtration Unit

 

BaySaver Technologies, an Advanced Drainage Systems, Inc. (ADS) company, has launched the Barracuda™ S4, a high-performance hydrodynamic separator that removes sediment and other debris from storm water run-off, further protecting water resources. The Barracuda S4 is designed with revolutionary, patent pending internal” teeth,” that mitigate turbulence in the storage chamber to prevent re-suspension of captured contaminants.

 

"Evolving requirements related to stormwater management have created demand for a more complete treatment methodology,” stated Joe Chlapaty, Chairman and Chief Executive Officer at ADS. “This innovative addition to our BaySaver line meets that need and extends our commitment to providing holistic and cost-effective water management solutions for our customers.”

 

The Barracuda S4, is designed to be used in a single manhole configuration and offers multiple pipe configurations, flexible inlet/outlet positioning, quick installation, easy inspection and maintenance.

 

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.